CORRECTION: Bio-Rad Laboratories Q3 Adj. EPS $2.26 Beats $1.93 Estimate, Sales $653.000M Beat $651.301M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $1.93 by 16.92 percent. This is a 11.88 percent increase over earnings of $2.02 per share from
Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $1.93 by 16.92 percent. This is a 11.88 percent increase over earnings of $2.02 per share from the same period last year. The company reported quarterly sales of $653.000 million which beat the analyst consensus estimate of $651.301 million by 0.26 percent. This is a 0.50 percent increase over sales of $649.729 million the same period last year.